Changes of systemic immune response after stereotactic ablative radiotherapy (SABR) - first results of a prospective study in early lung cancer patients

Jacek
Rutkowski
Tomasz
Ślebioda
Zbigniew
Kmieć
Renata
Zaucha
Pol Arch Intern Med
2017
Published online: 
April 18, 2017

tabs-grup